| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/19/2004 | US20040162254 Antiviral oligonucleotides targeting HSV and CMV |
| 08/19/2004 | US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 08/19/2004 | US20040162252 Administering formulation capable of inhibiting at least one host cell protein needed for replication of a virus |
| 08/19/2004 | US20040162251 Pharmaceutical composition containing decoy and method of using the same |
| 08/19/2004 | US20040162250 Remedy and preventive for diseases caused by NF-kB |
| 08/19/2004 | US20040162249 To inhibit the growth of tumor cells in mammals |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040162235 Forming a complex of polyampholyte and siRNA; and, delivering the complex into a cell |
| 08/19/2004 | US20040161858 TNF binding ligands and antibodies |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161848 Adenoviral vector and related system and methods of making and use |
| 08/19/2004 | US20040161847 Plasimd comprising regulatory sequence for cardiac specific expression of heterologous nucleotide sequences and proteins; tissue engineering; gene therapy and drug delivery |
| 08/19/2004 | US20040161846 Producing variant viral protein from negative sense single-stranded RNA virus for use as tool in vaccine development and prevention of viral infections; viricides |
| 08/19/2004 | US20040161841 Vector coding triosephosphate isomerase and heterologous nucleotide sequences for use in producing genetic vaccines; bioreactors |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161839 Method to alter sugar moieties |
| 08/19/2004 | US20040161837 Using affinity chromatography to isolate lysosomal proteins from mammalian milk; for enzyme replacement therapy and treating pompe's disease |
| 08/19/2004 | US20040161836 Recombinant porcine liver esterases, their use and a method for the production thereof |
| 08/19/2004 | US20040161835 Polypeptide having alpha-isomaltosylglucosaccharide synthase activity |
| 08/19/2004 | US20040161832 Esterase, its DNA, its overexpression and production of optically active aryl propionic acids using the same |
| 08/19/2004 | US20040161828 Gene cluster for production of the enediyne antitumor antibiotic C-1027 |
| 08/19/2004 | US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening |
| 08/19/2004 | US20040161826 Comprises heat resistant enzymatic polypeptide for use in synthesizing amino acids, aimines, and prochiral ketones with high optical purity |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | US20040161820 for antibiotic resistance; includes glycol-amylase gene expression cassette; genetic engineering |
| 08/19/2004 | US20040161819 Isoprenoid synthases |
| 08/19/2004 | US20040161818 for use in pesticide bioremediation strategies; biosensors; genetic engineering; solid phase synthesis |
| 08/19/2004 | US20040161817 for gene overexpression in combination with an immortalized host cell-line capable of growth in serum-free, suspension culture |
| 08/19/2004 | US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161805 Cardiovascular safety assay |
| 08/19/2004 | US20040161801 Hybridization detection method and biochips |
| 08/19/2004 | US20040161799 KOR3like-proteins and methods of modulating KOR3L-mediated activity |
| 08/19/2004 | US20040161787 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | US20040161783 Using 16s ribosomal RNA subregions for use as differentiative tools in taxonomic classification of mycobacterium |
| 08/19/2004 | US20040161781 Identifying enzyme inhibitors and modulators which bind specific transcriptional elements for use in treatment of cell proliferative disorders |
| 08/19/2004 | US20040161771 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4 |
| 08/19/2004 | US20040161769 Comprises nucleotide sequences coding carotene-degrading oxidoreductase for use in detergents and preparation of food, cosmetics and perfume |
| 08/19/2004 | US20040161765 Screening for monogenic and polygenic genetic disorders using RNA interference and subtractive hybridization; prevention of premature translation termination |
| 08/19/2004 | US20040161764 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest |
| 08/19/2004 | US20040161762 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/19/2004 | US20040161761 Genetic testing |
| 08/19/2004 | US20040161758 Identifying/screening ruminant foods and products for presence of viral agents associated with spongiform encephalopathy; immunoassays |
| 08/19/2004 | US20040161757 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 08/19/2004 | US20040161756 Preparing solid support comprising immobilize nucleotide sequences coding receptor and/or enzymatic polypeptides for use in identifying modulators of genic expression |
| 08/19/2004 | US20040161755 Comprises nucleotide sequences coding kinesin protein for use in diagnosis, treatment or prevention of cancer, nervous system and vesicular transport disorders |
| 08/19/2004 | US20040161753 Identifying genic sequences of regulatory DNA binding proteins via directed mutational analysis; generating mimetic protein for regulating transcription |
| 08/19/2004 | US20040161752 Modular vector systems |
| 08/19/2004 | US20040161748 Gridded microarray created by transcription and translation of DNA, or by translation of mRNA, by a cell free system for generating heterologous proteins, domains or peptides; bioreactors |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161744 Reaction apparatus and method of analyzing biologically active substances using the same |
| 08/19/2004 | US20040161743 Applications with and methods for producing selected interstrand cross-links in nucleic acids |
| 08/19/2004 | US20040161741 Microarray comprising immobilized nucleotide sequences and/or derivatives for quantifying RNA expression products |
| 08/19/2004 | US20040161740 Method of determining the genetic material of cocoa in fermented or roasted beans and chocolate |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161738 Using endothelial cells to isolate and recover phage which preferentially bind blood-brain barrier proteins; for use as drug targeting tool in treating brain disorders; drug delivery; tissue targeted therapy |
| 08/19/2004 | US20040161735 Cryopreserving porcine embryos using centfirugation to polarize cytoplasmic lipids, expose oocytes/embryos to low temperature conditions and cryoprotectant, store until ready for use |
| 08/19/2004 | US20040161463 Supplying, condensation,forming nucleic acids binding polymers |
| 08/19/2004 | US20040161432 Subunit vaccines and processes for the production thereof |
| 08/19/2004 | US20040161420 Designed for bacterial live vector vaccines; does not rely on antibiotic resistance; stability |
| 08/19/2004 | US20040161418 Adeno-associated virus vector for boosting immunogenicity of cells |
| 08/19/2004 | US20040161417 Inhibiting expression of invariant chain protein (li) in antigen presenting cells |
| 08/19/2004 | US20040161416 Delivering DNA sequence imparting sustained rheumatoid arthritis relief |
| 08/19/2004 | US20040161413 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 08/19/2004 | US20040161411 Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system |
| 08/19/2004 | US20040161410 Involving nucleotide sequence 15 or 19; efficient, well tolerated |
| 08/19/2004 | US20040161408 Uses of circadian gene mPer2 |
| 08/19/2004 | CA2773059A1 Bead emulsion nucleic acid amplification |
| 08/19/2004 | CA2743564A1 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 08/19/2004 | CA2515644A1 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | CA2515623A1 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | CA2515603A1 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | CA2515554A1 Oligomeric compounds for the modulation of thioredoxin expression |
| 08/19/2004 | CA2515333A1 Control of plant growth and developmental processes |
| 08/19/2004 | CA2515107A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2515000A1 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | CA2514983A1 Novel supported catalyst systems |
| 08/19/2004 | CA2514941A1 High-expression vector for animal cells |
| 08/19/2004 | CA2514843A1 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | CA2514838A1 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | CA2514694A1 Mevalonate kinase as a target for fungicides |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/19/2004 | CA2514450A1 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 08/19/2004 | CA2513889A1 Double ended sequencing |
| 08/19/2004 | CA2513833A1 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | CA2513541A1 Method for preparing single-stranded dna libraries |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | CA2512051A1 Immunoglobulin |
| 08/18/2004 | EP1447453A1 System for inducible, local and reversible gene silencing using RNA interference |
| 08/18/2004 | EP1447451A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND-BETA2m AND UTILIZATION THEREOF |
| 08/18/2004 | EP1447450A1 Method of regulating expression of gene carried on viral vector |
| 08/18/2004 | EP1447449A1 PROCESSES FOR PRODUCING BETA-1,3-n-ACETYLGLUCOSAMINE TRANSFERASE AND N-ACETYLGLUCOSAMINE-CONTAINING COMPOSITE SACCHARIDE |
| 08/18/2004 | EP1447448A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 08/18/2004 | EP1447447A1 Process for producing aplha2,3/alpha2,8-sialyltransferase and sialic acid-containing complex sugar |